High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05215327 |
|
Recruitment Status :
Recruiting
First Posted : January 31, 2022
Last Update Posted : November 29, 2023
|
Sponsor:
Vanderbilt University Medical Center
Collaborators:
Northwestern University Feinberg School of Medicine
University of Alabama at Birmingham
University of Washington
Duke University
Information provided by (Responsible Party):
Natasha Halasa, Vanderbilt University Medical Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | July 2027 |
| Estimated Study Completion Date : | December 2027 |